Choose Language
Select a language for news translation.
Written by Ryan Vanzo for The Motley Fool Key Points SpaceX's growth potential will take years to play out. Investors should remember the key drivers of Space…
Ken Fisher's latest disclosed positions put two different approaches to AI infrastructure and security in the same portfolio. Cisco Systems, Inc. (NASDAQ: CSCO…
Dan Loeb's Third Point disclosed exposure to Hut 8 Corp. (NASDAQ: HUT ) and Riot Platforms, Inc. (NASDAQ: RIOT ) in its latest quarterly filing. The security t…
Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. When the CEOs of trillion-dollar companies issue the same w…
Hooker Furnishings reported Q2 2027 revenue of $1.3 billion and EPS of $2.45, beating estimates. Strong online sales and operational efficiency drove the resul…
Written by Eric Volkman for The Motley Fool Key Points The social media titan kept its dividend level. This was encouraging, but it shouldn't be anyone's prim…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) could be positioning itself for its next major phase of growth following its roughly $10 billion acquisitio…
Written by James Brumley for The Motley Fool Key Points Assuming history repeats itself, the Nasdaq Composite could roughly triple in value over the course of…
RedHill Biopharma Ltd. (NASDAQ: RDHL ) acquired exclusive global commercialization rights to Rebyota and exclusive U.S. commercialization rights to Clenpiq fro…
US stocks sank on Thursday morning as oil prices and Treasury yields continued to climb and investors assessed fresh wholesale inflation data. The Dow Jones I…
On September 3, AbbVie Inc. (NYSE: ABBV ) finalized its acquisition of clinical-stage biotech Apogee Therapeutics, Inc. (NASDAQ: APGE ) for $135.11 per share i…
